Kyttaris VC - Search Results

1

Pin1-Targeted Therapy for Systemic Lupus Erythematosus.

Wei S, Yoshida N, Finn G, Kozono S, Nechama M, Kyttaris VC, Zhen Zhou X, Tsokos GC, Ping Lu K. Wei S, et al. Among authors: kyttaris vc. Arthritis Rheumatol. 2016 Oct;68(10):2503-13. doi: 10.1002/art.39741. Arthritis Rheumatol. 2016. PMID: 27159270 Free PMC article.

2

Uncovering the genetics of systemic lupus erythematosus: implications for therapy.

Kyttaris V, Tsokos G. Kyttaris V, et al. Am J Pharmacogenomics. 2003;3(3):193-202. doi: 10.2165/00129785-200303030-00005. Am J Pharmacogenomics. 2003. PMID: 12814327 Review.

3

Gene therapy in systemic lupus erythematosus.

Kyttaris VC, Juang YT, Tsokos GC. Kyttaris VC, et al. Lupus. 2004;13(5):353-8. doi: 10.1191/0961203304lu1026oa. Lupus. 2004. PMID: 15230292 Review.

4

T lymphocytes in systemic lupus erythematosus: an update.

Kyttaris VC, Tsokos GC. Kyttaris VC, et al. Curr Opin Rheumatol. 2004 Sep;16(5):548-52. doi: 10.1097/01.bor.0000132646.55056.e0. Curr Opin Rheumatol. 2004. PMID: 15314492 Review.

5

Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus.

Kyttaris VC, Juang YT, Tenbrock K, Weinstein A, Tsokos GC. Kyttaris VC, et al. J Immunol. 2004 Sep 1;173(5):3557-63. doi: 10.4049/jimmunol.173.5.3557. J Immunol. 2004. PMID: 15322221

6

Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.

Juang YT, Wang Y, Solomou EE, Li Y, Mawrin C, Tenbrock K, Kyttaris VC, Tsokos GC. Juang YT, et al. Among authors: kyttaris vc. J Clin Invest. 2005 Apr;115(4):996-1005. doi: 10.1172/JCI22854. J Clin Invest. 2005. PMID: 15841182 Free PMC article.

7

Immune cells and cytokines in systemic lupus erythematosus: an update.

Kyttaris VC, Juang YT, Tsokos GC. Kyttaris VC, et al. Curr Opin Rheumatol. 2005 Sep;17(5):518-22. doi: 10.1097/01.bor.0000170479.01451.ab. Curr Opin Rheumatol. 2005. PMID: 16093827 Review.

8

Increased caspase-3 expression and activity contribute to reduced CD3zeta expression in systemic lupus erythematosus T cells.

Krishnan S, Kiang JG, Fisher CU, Nambiar MP, Nguyen HT, Kyttaris VC, Chowdhury B, Rus V, Tsokos GC. Krishnan S, et al. Among authors: kyttaris vc. J Immunol. 2005 Sep 1;175(5):3417-23. doi: 10.4049/jimmunol.175.5.3417. J Immunol. 2005. PMID: 16116236

9

Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC. Katsiari CG, et al. Among authors: kyttaris vc. J Clin Invest. 2005 Nov;115(11):3193-204. doi: 10.1172/JCI24895. Epub 2005 Oct 13. J Clin Invest. 2005. PMID: 16224536 Free PMC article.

10

New insights into the pathogenesis of systemic lupus erythematosus.

Kyttaris VC, Katsiari CG, Juang YT, Tsokos GC. Kyttaris VC, et al. Curr Rheumatol Rep. 2005 Dec;7(6):469-75. doi: 10.1007/s11926-005-0054-3. Curr Rheumatol Rep. 2005. PMID: 16303108 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters